Abnormal alpha-1 antitrypsin levels and other risk factors associated with lung function impairment at 6 and 12 months after hospitalization due to covid-19: a cohort study

HIGHLIGHTS

• who: Beatriz Maru00eda Jimu00e9nez-Rodru00edguez and colleagues from the after Hospitalization Due to COVID-19: A Cohort Study Department of Pneumology, University Hospital Virgen de las Nieves, Granada, Spain have published the paper: Abnormal Alpha-1 Antitrypsin Levels and Other Risk Factors Associated with Lung Function Impairment at 6 and 12 Months after Hospitalization Due to COVID-19: A Cohort Study, in the Journal: Healthcare 2022, 2341 of /2022/
• what: The authors aimed to identify the medical conditions that may influence lung function impairment at 12 months after SARS-CoV2 infection and to analyze the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.